1. Home
  2. ALDX vs PSTL Comparison

ALDX vs PSTL Comparison

Compare ALDX & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • PSTL
  • Stock Information
  • Founded
  • ALDX 2004
  • PSTL 2018
  • Country
  • ALDX United States
  • PSTL United States
  • Employees
  • ALDX N/A
  • PSTL N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • PSTL Real Estate Investment Trusts
  • Sector
  • ALDX Health Care
  • PSTL Real Estate
  • Exchange
  • ALDX Nasdaq
  • PSTL Nasdaq
  • Market Cap
  • ALDX 133.7M
  • PSTL 311.3M
  • IPO Year
  • ALDX 2014
  • PSTL 2019
  • Fundamental
  • Price
  • ALDX $2.16
  • PSTL $12.57
  • Analyst Decision
  • ALDX Strong Buy
  • PSTL Strong Buy
  • Analyst Count
  • ALDX 2
  • PSTL 1
  • Target Price
  • ALDX $9.50
  • PSTL $16.50
  • AVG Volume (30 Days)
  • ALDX 1.5M
  • PSTL 199.4K
  • Earning Date
  • ALDX 05-20-2025
  • PSTL 04-30-2025
  • Dividend Yield
  • ALDX N/A
  • PSTL 7.51%
  • EPS Growth
  • ALDX N/A
  • PSTL 176.54
  • EPS
  • ALDX N/A
  • PSTL 0.28
  • Revenue
  • ALDX N/A
  • PSTL $81,235,000.00
  • Revenue This Year
  • ALDX N/A
  • PSTL $14.67
  • Revenue Next Year
  • ALDX N/A
  • PSTL $11.15
  • P/E Ratio
  • ALDX N/A
  • PSTL $44.68
  • Revenue Growth
  • ALDX N/A
  • PSTL 23.36
  • 52 Week Low
  • ALDX $1.14
  • PSTL $12.26
  • 52 Week High
  • ALDX $7.20
  • PSTL $15.15
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 34.82
  • PSTL 34.14
  • Support Level
  • ALDX $1.90
  • PSTL $12.26
  • Resistance Level
  • ALDX $2.89
  • PSTL $13.59
  • Average True Range (ATR)
  • ALDX 0.23
  • PSTL 0.33
  • MACD
  • ALDX 0.10
  • PSTL -0.05
  • Stochastic Oscillator
  • ALDX 26.26
  • PSTL 20.39

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About PSTL Postal Realty Trust Inc.

Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.

Share on Social Networks: